InvestorsHub Logo
Followers 63
Posts 1756
Boards Moderated 0
Alias Born 09/21/2016

Re: nidan7500 post# 166531

Monday, 09/24/2018 8:37:11 AM

Monday, September 24, 2018 8:37:11 AM

Post# of 461432
Thanks, nidan!

You put that very well!

“Anavex now has a CNS story to tell.”

And we have the evidence to back up that it is working and we have the ability to demonstrate that it can (and will) be duplicated - the proof necessary to prove a hypothesis.

You could not be more correct or insightful that at this point - the Amyloid theory becomes the “isolated anecdote” as opposed to the targeted therapy of precision medicine. (Amyloid - the isolated anecdotal evidence , which failed, it can now be added.)

Yes, it’s time to roll out our media campaign to get everyone in the field and the world accustomed to the new approach. This should be very doable with the experts and body of evidence we are prepared to call to testify on behalf of the scientifically compelling method used to unravel the previous snares. We let the data lead - not a hypothesis! This is what the data led to - we just followed it to a stabilizing outcome. That’s good scientific methodology. We rejected what wasn’t working, didn’t follow the paths where the data was not leading us, unlike all the previous Amyloid explorers.

So, yes, now is the time all ears and minds should be open to hear a NEW STORY, OUR STORY.

ANAVEX HAS A CNS STORY TO TELL!

Great call!

Now, we can begin to make our launch into the spotlight and occupy CNS -Central!

Kudos - Very thoughtful post!
Bio
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News